NCT01018550View on ClinicalTrials.gov

AMG 853 Phase 2 Study in Subjects With Inadequately Controlled Asthma

PHASE2CompletedINTERVENTIONAL

Enrollment

397

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

March 31, 2011

Conditions

Asthma

Interventions

DRUG

AMG 853

AMG 853 5 mg (BID)

DRUG

AMG 853

AMG 853 200 mg (QD)

DRUG

AMG 853

AMG 853 25 mg (BID)

DRUG

AMG 853

AMG 853 100 mg (BID)

DRUG

Placebo

Placebo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY